Skip to content
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
TNC FlipBook Classic items
30062025-PR_Report_2024_Accounts_II_EN
By
admin
July 1, 2025
190625_CP_ Suspension_de_la_cotation_FR
By
admin
June 24, 2025
190625_PR_Suspension_of_Trading_EN
By
admin
June 24, 2025
040625_CP_Participation_BIO_US_EN
By
admin
June 3, 2025
040625_CP_Participation_BIO_US_FR
By
admin
June 3, 2025
2025-05-30_CP_Report_AGO_Approbation_Comptes_2024_FR
By
admin
May 30, 2025
2025-05-30_PR_New_Report_2024_Results_EN
By
admin
May 30, 2025
Biophytis_ECO_CONGRESS_EN
By
admin
May 14, 2025
Biophytis_ECO_CONGRESS_FR
By
admin
May 14, 2025
25042025-CP_Report_Publication_FR
By
admin
April 25, 2025
←
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
…
21
22
23
24
25
…
26
27
28
29
30
31
32
33
34
→
Go to Top
Home
About Us
Longevity Platform
Bio101
BIO101 in Sarcopenia
BIO101 in Obesity
Biophytis Biopharmaceutical
Other Projects
Resources
Posters & Publications
Scientific Press Releases
Recruitment
Investors
Stock Information
Corporate Presentation
Letter to shareholders
Press Releases
General Meetings
AMF Regulated Information
SEC Filings
Convertible bonds
Pre-financed vouchers (PFW)
Obligations Hexagon
Obligations Hexagon
Contact for Investors
Contact
